Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 15, 2010Journal of Clinical OncologyOpen Access

Genetics of Biliary Tract Cancers and Emerging Targeted Therapies

View Full Paper
Ask AI
Bookmark
Share

Authors

AHAram F. HezelUniversity of Rochester Medical Center
Vikram Deshpande
Vikram DeshpandeBoston UniversityAZAndrew X. ZhuUniversity of Pisa

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hezel et al. (2010) studied this question.

synapsesocial.com/papers/6a193dfab71d9c859388cbc3https://doi.org/10.1200/jco.2009.27.4787
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis2001 · 119 citations
  2. 2A novel “patient‐like” model of cholangiocarcinoma progression based on bile duct inoculation of tumorigenic rat cholangiocyte cell lines†‡2007 · 84 citations
  3. 3Establishment of a novel rat cholangiocarcinoma cell culture model1999 · 21 citations